Literature DB >> 690243

A clinicopathological study of liver disease in haemophiliacs.

P M Mannucci, G Ronchi, L Rota, M Colombo.   

Abstract

Chronic liver disease is not often reported in patients with haemophilia. Although a high incidence of abnormal liver function tests has been reported, the clinical significance of these findings and their relation to chronic liver disease cannot be established without a liver biopsy. The results of this procedure, carried out in 11 patients with severe haemophilia A and B, in whom SGOT had been persistently raised for three years, are reported. Five patients had chronic active hepatitis, four had chronic persistent hepatitis, one had cirrhosis, and one alcoholic hepatitis. No haemorrhagic complication followed the biopsy procedure, which was carried out in patients given prophylactic clotting factor concentrates. These results suggest that duration of abnormal liver function tests is likely to represent liver disease in haemophiliacs, and that biopsy should be considered to establish the diagnosis and plan a suitable therapeutic programme.

Entities:  

Mesh:

Year:  1978        PMID: 690243      PMCID: PMC1145406          DOI: 10.1136/jcp.31.8.779

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Editorial: Tolerating hepatitis.

Authors:  G Grady
Journal:  N Engl J Med       Date:  1974-07-11       Impact factor: 91.245

2.  Characterization and properties of an inhibitor of factor 8 in the plasma of patients with hemophilia A following repeated transfusions.

Authors:  H S Strauss; E Merler
Journal:  Blood       Date:  1967-08       Impact factor: 22.113

3.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

Authors:  W T London; M Di Figlia; A Sutnick; B S Blumberg
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

4.  Liver diseases in asymptomatic carriers of hepatitis B antigen.

Authors:  J B Simon; S K Patel
Journal:  Gastroenterology       Date:  1974-05       Impact factor: 22.682

5.  Asymptomatic liver disease in hepatitis B antigen carriers.

Authors:  I L Woolf; B E Boyes; D M Jones; J S Whittaker; E Tapp; R N MacSween; P H Renton; F Stratton; I W Dymock
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411

6.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

7.  Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Authors:  S W Schalm; W H Summerskill; G L Gitnick; L R Elveback
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

8.  Liver biopsy in hemophilia A.

Authors:  H R Lesesne; J E Morgan; P M Blatt; W P Webster; H R Roberts
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

9.  Chronic hepatitis in hemophilia.

Authors:  U Hasiba; J A Spero; J H Lewis
Journal:  Scand J Haematol Suppl       Date:  1977

10.  Liver dysfunction in patients with hemophilia.

Authors:  M W Hilgartner; P Giardina
Journal:  Scand J Haematol Suppl       Date:  1977
View more
  5 in total

1.  Hepatitis B virus infection in multitransfused haemophiliacs.

Authors:  G Nebbia; G A Moroni; L Simoni; M Belli; V Carnelli
Journal:  Arch Dis Child       Date:  1986-06       Impact factor: 3.791

2.  Liver function in Edinburgh haemophiliacs: a five-year follow-up.

Authors:  M L Stirling; G J Beckett; I W Percy-Robb
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

3.  Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.

Authors:  S De Virgiliis; G Fiorelli; S Fargion; G Cornacchia; G Sanna; P Cossu; V Murgia; A Cao
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

4.  Liver disease complicating severe haemophilia in childhood.

Authors:  K M McGrath; J S Lilleyman; D R Triger; J C Underwood
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

5.  Coagulation factor therapy for hemophilia: relation to hepatitis B and to liver function.

Authors:  R T Card; M Dusevic; B E Lukie
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.